Detalhe da pesquisa
1.
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
J Gastroenterol Hepatol
; 35(8): 1412-1419, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31896166
2.
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.
J Med Virol
; 91(4): 650-658, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30381831
3.
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.
Hepatol Res
; 48(2): 193-204, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28544062
4.
Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma.
Hepatol Res
; 48(13): 1118-1130, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30030881
5.
Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.
J Med Virol
; 89(4): 665-671, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27602542
6.
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
J Med Virol
; 89(11): 1963-1972, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28657143
7.
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures.
Intern Med
; 60(6): 829-837, 2021 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33087674
8.
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.
Hepatol Commun
; 3(3): 348-355, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30859147
9.
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.
PLoS One
; 13(4): e0195028, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29614124
10.
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
J Gastroenterol
; 53(1): 107-118, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28474222
11.
Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia.
Clin J Gastroenterol
; 10(4): 383-387, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28597413
12.
Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.
J Gastroenterol
; 52(12): 1252-1257, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28477171
13.
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
PLoS One
; 12(8): e0182710, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28797106
14.
Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
J Gastroenterol
; 53(1): 161-162, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28555325